» Articles » PMID: 36394680

The Diagnostic Role of "acceleration Time" Measurement in Patients with Classical Low Flow Low Gradient Aortic Stenosis with Reduced Left Ventricular Ejection Fraction

Overview
Publisher Springer
Specialty Radiology
Date 2022 Nov 17
PMID 36394680
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In our study, we aimed to assess the role of acceleration time (AT), ejection time (ET), and AT/ET ratio to distinguish between true and pseudo severe AS in patients with classical low flow-low gradient (LF-LG) aortic stenosis (AS) with reduced left ventricular ejection fraction (LVEF).

Methods: Sixty-seven classical LF-LG AS with reduced LVEF patients who underwent dobutamine stress echocardiography (DSE) were included in the study. According to DSE results, all patients were divided into two groups; true AS and pseudo severe AS. Aortic valve calcium score was measured in patients with inconclusive DSE results. AT and other ejection dynamics (ET and AT/ET) were calculated by taking baseline echocardiographic records into account for all patients. The predictive power of AT and other ejection dynamics were evaluated to estimate true and pseudo severe AS.

Results: According to DSE results, out of 67 patients, 44 (65.7%) was diagnosed as true severe AS. There was a statistically significant relation between baseline AT and true AS [adjusted OR 4.47 (95% CI 1.93-10.4), p = 0.001]. The best cutoff value of AT was measured as 100 msec according to the Youden index. This value had a sensitivity value of 77%, specificity value of 87%, positive predictive value of 92%, and a negative predictive value of 67%.

Conclusion: The measurement of AT can predict the DSE outcome and can be used for diagnostic purposes to distinguish between true and pseudo severe AS in classical LF-LG AS patients with reduced LVEF.

Citing Articles

Aortic Valve Calcium Score: Applications in Clinical Practice and Scientific Research-A Narrative Review.

Gac P, Jaworski A, Grajnert F, Kicman K, Trejtowicz-Sutor A, Witkowski K J Clin Med. 2024; 13(14).

PMID: 39064103 PMC: 11277735. DOI: 10.3390/jcm13144064.

References
1.
Baumgartner H, Hung J, Bermejo J, Chambers J, Edvardsen T, Goldstein S . Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017; 30(4):372-392. DOI: 10.1016/j.echo.2017.02.009. View

2.
Otto C, Nishimura R, Bonow R, Carabello B, Erwin 3rd J, Jneid H . 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021; 162(2):e183-e353. DOI: 10.1016/j.jtcvs.2021.04.002. View

3.
Iung B, Baron G, Butchart E, Delahaye F, Gohlke-Barwolf C, Levang O . A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13):1231-43. DOI: 10.1016/s0195-668x(03)00201-x. View

4.
Clavel M, Berthelot-Richer M, Le Ven F, Capoulade R, Dahou A, Dumesnil J . Impact of classic and paradoxical low flow on survival after aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2015; 65(7):645-53. DOI: 10.1016/j.jacc.2014.11.047. View

5.
Clavel M, Burwash I, Mundigler G, Dumesnil J, Baumgartner H, Bergler-Klein J . Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. J Am Soc Echocardiogr. 2010; 23(4):380-6. DOI: 10.1016/j.echo.2010.02.002. View